The antioxidant role of selenium and seleno-compounds

Biomedicine and Pharmacotherapy

Volumn 57, Issue 3, 2003, Pages 134-144

  Tapiero, H ^a   Townsend, D M ^b   Tew, K D ^b  

^a UNIV PARIS SUD   (France)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Glutathione peroxidase; Selenium; Selenoproteins; Thioredoxin system

Indexed keywords

1,4 PHENYLENE BIS(METHYLENE)SELENOCYANATE; 4 METHOXYBENZENESELENOL; ANTIOXIDANT; BENZYLSELENOCYANATE; DEXAMETHASONE; DIPHENYL SELENIDE; ETOPOSIDE; GLUTATHIONE PEROXIDASE; LIOTHYRONINE; METHIONINE SULFOXIDE REDUCTASE B; ORGANOSELENIUM DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SELENIUM DERIVATIVE; SELENOAMINO ACID; SELENODIGLUTATHIONE; SELENOMETHIONINE; SELENOPROTEIN; SELENOPROTEIN P; SELENOPROTEIN W; SODIUM SELENITE; SPHINGOSINE DERIVATIVE; STAUROSPORINE; THAPSIGARGIN; THIOREDOXIN; THIOREDOXIN REDUCTASE; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE; TRIPHENYLSELENONIUM; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BROCCOLI; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARCINOMA CELL; CARDIOMYOPATHY; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CORONARY ARTERY DISEASE; CYTOPATHOGENIC EFFECT; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DNA SYNTHESIS; ENDEMIC DISEASE; FOOD COMPOSITION; GARLIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; KASHIN BECK DISEASE; KERATINOCYTE; KESHAN DISEASE; MUSCLE WEAKNESS; NAIL DISEASE; NONHUMAN; OSTEOARTHROPATHY; PAIN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SELENIUM DEFICIENCY; T LYMPHOCYTE;

EID: 0038719775     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(03)00035-0     Document Type: Article

References (152)

1. Vendeland S.C., Deagen J.T., Butler J.A., Whanger P.D. Uptake of selenite, selenomethionine and selenate by brush border membrane vesicles isolated from rat small intestine. Biometals. 7:1994;305-312.
2. Jackson M.J. The assessment of bioavailability of micronutrients: introduction. Eur J Clin Nutr. 51:1997;S1-S2.
3. Waschulewski I.H., Sunde R.A. Effect of dietary methionine on tissue selenium and glutathione peroxidase on tissue selenium and glutathione peroxidase activity given selenomethionine. Br J Nutr. 60:1988;57-68.
4. Fairweather-Tait S.J. Bioavailability of selenium. Eur J Clin Nutr. 51:1997;S20-S23.
5. King J.C. Effect of reproduction on the bioavailability of calcium, zinc and selenium. J Nutr. 131:2001;1355S-1358S.
6. McGuire M.K., Burgert S.S.L., Milner J.A., et al. Selenium status of lactating women is affected by the form of selenium consumed. Am J Clin Nutr. 58:1993;649-652.
7. Michalke B., Schramel P. Selenium speciation in human milk with special respect to quality control. Biol Trace Elem Res. 59:1997;45-56.
8. Ganther H.E. Pathways of selenium metabolism including respiratory excretory products. J Am Coll Toxicol. 5:1986;1-5.
9. Gronbaek H., Thorlacius-Ussing O. Selenium in the central nervous system of rats exposed to 75-Se selenomethionine and sodium selenite. Biol Trace Elem Res. 35:1992;119-127.
10. Hill K.E., Burk R.F., Lane J.M. Effect of selenium depletion and repletion on plasma glutathione and glutathione-dependent enzymes in the rat. J Nutr. 117:1987;99-104.
11. Burk R.F., Hill K.E., Awad J.A., Morrow J.D., Lyons P.R. Liver and kidney necrosis in selenium deficient rats depleted of glutathione. Lab Invest. 72:1995;723-730.
12. Uthus E.O., Yokoi K., Davis C.D. Selenium deficiency in Fisher-344 rats decreases plasma and tissue homocysteine concentrations and alters plasma homocysteine and cysteine redox status. J Nutr. 132:2002;1122-1128.
13. Tapiero H., Tew K.D., Gaté L., Machover D. Prevention of pathologies associated with oxidative stress and dietary intake deficiencies: folate deficiencies and requirements. Biomed Pharmacother. 55:2001;381-390.
14. Ashfield-Watt P.A.L., Moat S.J., Doshi S.N., McDowell I.F.W. Folate homocysteine, endothelial function and cardiovascular disease. What is the link? Biomed Pharmacother. 55:2001;425-433.
15. Chern C.-L., Huang R.-F.S., Chen J.-T., Cheng T.-Z.L. Folate deficiency induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-κB in human Hep G2 cells. Biomed Pharmacother. 55:2001;434-442.
16. Jakubowski H. Protein N homocysteinylation: implications for atherosclerosis. Biomed Pharmacother. 55:2001;443-447.
17. Valera-Moreiras G. Nutritional regulation of homocysteine: effects of drugs. Biomed Pharmacother. 55:2001;448-453.
18. Beck M., Shi Q., Morris V., Levander O. Rapid genomic evolution of a non-virulent Coxsackie virus B3 in selenium deficient mice results in selection of identical isolates. Nature M. 1:1995;433-441.
19. Davis C.D., Uthus E.O. Dietary selenium and azadeoxycytidine treatment affect dimethylhydrazine-induced aberrant crypt formation in rat liver colon and DNA methylation in HT-29 cells. J Nutr. 132:2002;292-297.
20. Ganapathy S.N., Thimaya S. Watson R.R. Trace elements in human health and disease. vol. 3:1985;111-122 CRC Press, Boca Raton, FL.
21. Vanderpas J.B., Contempre B., Duale N.L., et al. Iodine and selenium deficiencies associated with cretinism in northern Zaïre. Am J Clin Nutr. 52:1990;1087-1093.
22. Vanderpas J.B., Contempre B., Duale N.L., et al. Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am J Clin Nutr. 57:1993;271S-275S.
23. Cheng Y.Y., Qian P.C. The effect of selenium-fortified table salt in the prevention of Keshan disease on a population of 1.05 million. Biomed Environ Sci. 3:1990;422-428.
24. Aro A., Kumpulainen J., Alfthan G., et al. Factors affecting the selenium intake of people in transbaikalian Russia. Biol Trace Element Res. 40:1994;277-285.
25. Ferrans V.J. Pathologic anatomy of the dilated cardiomyopathies. Am J Cardiol. 64:1989;9C-11C.
26. Arthur J.R., Beckett G.J. Thyroid function: review. Br Med Bull. 55:1999;658-668.
27. Allander E. Kashin-Beck disease. An analysis of research and public health activities based on a bibliography 1849-1992. Scand J Rheumatol Suppl. 99:1994;1-36.
28. Yang C., Niu C., Bodo M., et al. Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. An animal model to study the molecular defects of Kashin-Beck disease. Biochem J. 289:1993;829-835.
29. Peng A., Wang W.H., Wang C.X., et al. The role of humic substances in drinking water in Kashin-Beck disease in China. Environ Health Perspect. 107:1999;293-296.
30. Chasseur C., Suetens C., Nolard N., Begaux F., Haubruge E. Fungal contamination in barley and Kashin-Beck disease in Tibet. Lancet. 350:1997;1074.
31. Burk R.F., Hill K.E. Regulation of selenoproteins. Annu Rev Nutr. 13:1993;65-81.
32. Behne D., Weiss-Nowak C., Kalklösch M., et al. Studies on the distribution and characteristics of new mammalian selenium-containing proteins. Analyst. 120:1995;823-825.
33. Tamura T., Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cells: purification, properties and thioredoxin reductase activity. Proc Natl Acad Sci USA. 93:1996;1006-1011.
34. Gladyshev V.N., Hatfield D.L. Review: selenocysteine-containing proteins in mammals. J Biomed Sci. 6:1999;151-160.
35. Brigelius-Flohe R. Review: tissue-specific functions of individual glutathione peroxidases. Free Radic Biol M. 27:1999;951-965.
36. Rotruck J.T., Pope A.L., Ganther H.E., et al. Selenium: biochemical role as a component of glutathione peroxidase. Science. 179:1973;588-590.
37. Chu F.-F., Doroshow J.S., Esworthy R.S. Expression, characterization and tissue distribution of a new cellular Se-dependent glutathione peroxidase, GSHPX-GI. J Biol Chem. 268:1993;2571-2576.
38. Takahashi K., Avissar N., Whithin J., Cohen H. Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys. 256:1987;677-686.
39. Ursini F., Maiorino M., Gregolin C. The selenoenzyme phospholipid hydroperoxide peroxidase. Biochim Biophys Acta. 839:1985;62-70.
40. Lei X.G., Evenson J.K., Thompson K.M., Sunde R.A. Glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase are differentially regulated in rats by dietary selenium. J Nutr. 125:1995;1438-1446.
41. Read R., Bellew T., Yang J.-G., et al. Se and amino acid composition of selenoprotein P, the major selenoprotein in rat serum. J Biol Chem. 265:1990;17899-17905.
42. Deagen J.T., Butler J.A., Zachara B.A., Whanger P.D. Determination of the distribution of Se between glutathione peroxidase, selenoprotein P and albumin in plasma. Anal Biochem. 208:1993;176-184.
43. Hill K.E., Xia Y., Akesson B., et al. Selenoprotein P concentration in plasma as an index of selenium status in selenium deficient and selenium supplemented Chinese subjects. J Nutr. 126:1996;138-145.
44. Burk R.F., Hill K.E., Read R., et al. Response of rat selenoprotein P to selenium administration and fate of its selenium. Am J Physiol. 261:1991;E26-30.
45. Hill K.E., Lloyd R.S., Burk R.F. Conserved nucleotide sequences in the open reading frame and 3′ untranslated region of selenoprotein P mRNA. Proc Natl Acad Sci USA. 90:1993;537-541.
46. Dreher I., Schmutzler C., Jakob F., Kohrle J. Expression of selenoproteins in various rat and human tissues and cell lines. J Trace Elem Med Biol. 11:1997;83-91.
47. Yang X., Hill K.E., Maguire M.J., Burk R.F. Synthesis and secretion of selenoprotein P by cultured rat astrocytes. Biochim Biophys Acta. 1474:2000;390-396.
48. Koga M., Tanaka H., Yomogida K., et al. Expression of selenoprotein messenger ribonucleic acid in the rat testis. Biol Reprod. 58:1998;261-265.
49. Mörk H., Al-Taie O.H., Bähr K., et al. Inverse mRNA expression of the selenocysteine-containing proteins GI-GPX and SeP in colorectal adenomas compared with adjacent normal mucosa. Nutr Cancer. 37:2000;108-116.
50. Tanaka T., Kondo S., Iwasa Y., Hiai H., Toyokuni S. Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. Am J Pathol. 156:2000;2149-2157.
51. Burk R.F., Hill K.E. Orphan selenoproteins. Bioassays. 21:1999;231-237.
52. Hill K.E., Lloyd R.S., Yang J.-G., Read R., Burk R.F. The cDNA for rat selenoprotein P contains 10 TGA codons in the open reading frame. J Biol Chem. 266:1991;10050-10053.
53. Yang J.-G., Hill K.E., Burk R.F. Dietary Se intake controls rat plasma selenoprotein P concentration. J Nutr. 119:1989;1010-1012.
54. Burk R.F., Hill K.E., Awad J.A., Morrow J.D., Kato T., Cockell K.A., et al. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology. 21:1995;561-569.
55. Burk R.F., Early D.S., Hill K.E., Palmer I.S., Boeglin M.E. Plasma selenium in patients with cirrhosis. Hepatology. 27:1998;794-798.
56. Gu Q.-P., Sun Y., Ream L.W., Whanger P.D. Selenoprotein W accumulates primarily in primate skeletal muscle, heart, brain and tongue. Mol Cell Biochem. 204:2000;49-56.
57. Yeh J.-Y., Beilstein M.A., Andrews J.S., Whanger P.D. Tissue distribution and influence of Se status on levels of Se-W. FASEB J. 9:1995;392-396.
58. Vendeland S.C., Beilstein M.A., Chen C.L., et al. Purification and properties of Se-W from rat muscle. J Biol Chem. 268:1993;17103-17107.
59. Vendeland S.C., Beilstein M.A., Yeh J.-Y., Ream W., Whanger P.D. Rat skeletal muscle Se-W: cDNA clone and mRNA modulation by dietary Se. Proc Natl Acad Sci USA. 92:1995;8749-8753.
60. Kryukov G.V., Kryukov V.M., Gladyshev V.N. New mammalian selenocysteine-containing proteins identified with an algorithm that searches for selenocysteine insertion sequence elements. J Biol Chem. 274:1999;33888-33897.
61. Björnstedt M., Kumar S., Björkhem L., Spyrou G., Holmgren A. Selenium and the thioredoxin and glutaredoxin systems. Biomed Environ Sci. 10:1997;271-279.
62. Gasdaska J.R., Kirkpatrick D.L., Montfort W., Kuperus M., Hill S.R., Bergrren M., et al. Biochem Pharmacol. 52:1996;1741-1747.
63. Sahaf B., Söderberg A., Spyrou G., Barral A.M., Pekkari K., Holmgren A., et al. Thioredoxin expression and localization in human cell lines: detection of full-length and truncated species. Exp Cell Res. 236:1997;181-192.
64. Baker A., Payne C.M., Briehl M.M., Powis G. Thioredoxine, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res. 57:1997;5162-5167.
65. Arner E.S., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 267:2000;6102-6109.
66. Hill K.E., McCollum G.W., Boeglin M.E., Burk R.F. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun. 234:1997;293-295.
67. Powis G., Gasdaska J.R., Gasdaska P.Y., et al. Selenium and the thioredoxin redox system: effects on cell growth and death. Oncol Res. 9:1997;303-312.
68. Gallegos A., Berggren M., Gasdaska J.R., Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res. 57:1997;4965-4970.
69. Rozell B., Hansson H.A., Luthman M., Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol. 38:1985;79-86.
70. Lee S.R., Kim J.R., Kwon K.S., Yoon H.W., Levine R.L., Ginsburg A., et al. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J Biol Chem. 274:1999;4722-4734.
71. Köhrle J. Thyroid hormone deiodination in target tissues - a regulatory role of the trace element selenium? Exp Clin Endocrinol. 102:1994;63-89.
72. Clugston G.A., Hetzel B.S. Iodine. 8th Shils M.E., Olson J.A., Shike M. Modern nutrition in health and disease. 1994;252-263 Lea & Febiger, Philadelphia, PA.
73. Contempré B., Dumont J.E., Denef J.-F., Many M.-C. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. J Eur Endocrinol. 133:1995;99-109.
74. Hotz C.S., Fitzpatrick D.W., Trick K.D., L'Abbé M.R. Dietary iodine and selenium interact to affect thyroid hormone metabolism of rats. J Nutr. 127:1997;1214-1218.
75. Ip C., Ganther H. Activity of methylated forms of selenium in cancer prevention. Cancer Res. 50:1996;1206-1211.
76. Ip C. Lessons from basic research in selenium and cancer prevention. J Nutr. 128:1998;1845-1854.
77. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 20:1999;1657-1666.
78. Combs G.F. Jr, Gray W.P. Chemopreventive agents: selenium. Pharmacol Ther. 79:1998;179-192.
79. Combs G.F. Jr, Clark L.C. Nutritional oncology. Heber D., Blackburn G.L., Go V.L.W. 1999;215 Academic Press Inc, New York.
80. Combs G.F. Jr. Selenium and cancer. Garewal H.S. Antioxidants and disease prevention. 1997;97-113 CRC Press, New York, NY.
81. Spyrou G., Björnstedt M., Skog S., Holmgren A. Selenite and selenate inhibit human lymphocyte growth via different mechanisms. Cancer Res. 56:1996;4407-4412.
82. Helzlsouer K.J., Alberg A.J., Norkus E.P., Morris J.S., Hoffman S.C., Comstock G.W. Prospective study of serum micronutrients and ovarian cancer. J Natl Cancer Inst. 88:1996;32-37.
83. Nayini J., el-Bayoumy K., Sugie S., Cohen L.A., Reddy B.S. Chemoprevention of experimental mammary carcinogenesis by the synthetic organoselenium compound, benzylselenocyanate, in rats. Carcinogenesis. 10:1989;509-512.
84. Willett W.C., Polk B.F., Morris J.S., Stampfer M.J., Pressel S., Rosner B., et al. Prediagnostic serum selenium and risk of cancer. Lancet. 2:1983;130-134.
85. van den Brandt P.A., Goldbohm R.A., van't Veer P., Bode P., Dorant E., Hermus R.J., et al. A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer. J Natl Cancer Inst. 85:1993;224-229.
86. Nomura A.M., Lee J., Stemmermann G.N., Combs G.F. Jr. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 9:2000;883-887.
87. Philipov P., Tzatchev K. Selenium concentrations in serum of patients with cerebral and extracerebral tumors. Zentralbl Neurochir. 49:1988;344-347.
88. Jaskiewicz K., Marasas W.F., Rossouw J.E., Van Niekerk F.E., Heine Tech E.W. Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer. 62:1988;2635-2639.
89. Miyamoto H., Araya Y., Ito M., Isobe H., Dosaka H., Shimizu T., et al. Serum selenium and vitamin E concentrations in families of lung cancer patients. Cancer. 60:1987;1159-1162.
90. Knekt P., Aromaa A., Maatela J., Alfthan G., Aaran R.K., Hakama M., et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst. 82:1990;864-868.
91. Westin T., Ahlbom E., Johansson E., Sandstrom B., Karlberg I., Edstrom S. Circulating levels of selenium and zinc in relation to nutritional status in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 115:1989;1079-1082.
92. Helzlsouer K.J., Comstock G.W., Morris J.S. Selenium, lycopene, alpha-tocopherol, beta-carotene, retinol, and subsequent bladder cancer. Cancer Res. 49:1989;6144-6148.
93. Burney P.G., Comstock G.W., Morris J.S. Serologic precursors of cancer: serum micronutrients and the subsequent risk of pancreatic cancer. Am J Clin Nutr. 49:1989;895-900.
94. Glattre E., Thomassen Y., Thoresen S.O., Haldorsen T., Lund-Larsen P.G., Theodorsen L., et al. Prediagnostic serum selenium in a case-control study of thyroid cancer. Int J Epidemiol. 18:1989;45-49.
95. Caygill C.P., Lavery K., Judd P.A., Hill M.J., Diplock A.T. Serum selenium and gastric cancer in two regions of Norfolk. Food Addit Contam. 6:1989;359-363.
96. Knekt P., Aromaa A., Maatela J., Alfthan G., Aaran R.K., Teppo L., et al. Serum vitamin E, serum selenium and the risk of gastrointestinal cancer. Int J Cancer. 42:1988;846-850.
97. Reinhold U., Biltz H., Bayer W., Schmidt K.H. Serum selenium levels in patients with malignant melanoma. Acta Derm Venereol. 69:1989;132-136.
98. Yoshizawa K., Willett W.C., Morris S.J., Stampfer M.J., Spiegelman D., Rimm E.B., et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst. 90:1998;1219-1224.
99. Clark L.C., Hixson L.J., Combs G.F. Jr, Reid M.E., Turnbull B.W., Sampliner R.E. Plasma selenium concentration predicts the prevalence of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev. 2:1993;41-46.
100. Burke K.E., Combs G.F., Gross E.G., et al. The effects of topical and oral L-selenomethionine on pigmentation and skin cancer induced by ultraviolet irradiation. Nutr Cancer. 17:1992;123-137.
101. Pence B.C., Delver E., Dunn D.M. Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol. 102:1994;759-761.
102. Diamond A.M., Dale P., Murray J.L., Grdina D.J. The inhibition of radiation-induced mutagenesis by the combined effects of selenium and the aminothiol WR-1065. Mutat Res. 356:1996;147-154.
103. Perchellet J.P., Abney N.L., Thomas R.M., Guislain Y.L., Perchellet E.M. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin. Cancer Res. 47:1987;477-485.
104. Shimazu F., Tappei A.L. Selenoamino acids decrease radiation damage to amino acids and proteins. Science (Washington, DC). 143:1964;369-371.
105. Willett W.C., Stampfer M.J. Selenium and cancer: whether selenium protects against cancer is still unknown. Br Med J. 297:1988;573-579.
106. Clark L.C., Combs G.F., Turnbull B.W., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. J Am Med Assoc. 276:1996;1957-1987.
107. Holden J., Gebhardt R., Davis C., Lurie D. A nationwide study of the selenium content and variability in white bread. J Food Comp Anal. 4:1991;183-195.
108. Finley J., Matthys L., Shuler T., Korynta E. Selenium content of foods purchased in North Dakota. Nutr Res. 16:1996;723-728.
109. 2 toxicity. Carcinogenesis. 16:1995;1579-1584.
110. Bjornstedt M., Kumar S., Holmgren A. Selenodiglutathione is a highly efficient oxidant of reduced thioredoxin and a substrate for mammalian thioredoxin reductase. J Biol Chem. 267:1992;8030-8034.
111. Lanfear J., Fleming J., Wu L., Webster G., Harrison P.R. The selenium metabolite selenodiglutathione induces p53 and apoptosis: relevance to the chemopreventive effects of selenium? Carcinogenesis. 15:1994;1387-1392.
112. Feng Y., Finley J., Davis C., et al. Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2-dimethyl-4-aminobiphenyl. Toxicol Appl Pharmacol. 157:1999;36-42.
113. Vadhanavikit S., Ip C., Ganther H. Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. Xenobiotica. 23:1993;731-745.
114. Ganther H.E., Lawrence J.R. Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention. Tetrahedron. 53:1997;12299-12310.
115. Jiang C., Jiang W., Ip C., Ganther H., Lu J. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinogen. 26:1999;213-225.
116. Ip C., Thompson H.J., Zhu Z., Ganther H.E. In vitro and in vivo studies of methylselenic acid: evidence that a monomethylated selenium metabolite is critical for cancer prevention. Cancer Res. 60:2000;2882-2886.
117. Cai X.-J., Block E., Uden P.c., et al. Allium chemistry: identification of selenoamino acids in ordinary and selenium enriched garlic, onion, and broccoli using gas chromatography with atomic emission detection. J Agric Food Chem. 43:1995;1754-1757.
118. Ip C., Lisk D.J. Characterization of tissue selenium profiles and anticarcinogenic responses in rats fed natural sources of selenium-rich products. Carcinogenesis. 15:1994;573-576.
119. Davis C.D., Zeng H., Finley J.W. Selenium enriched broccoli decreases intestinal tumorigenesis in multiple intestinal neoplasia mice. J Nutr. 132:2002;307-309.
120. Finley J.W., Davis C.D., Feng Y. Selenium from high selenium broccoli protects rats from colon cancer. J Nutr. 130:2000;2384-2389.
121. Ip C., Thompson H.J., Ganther H.E. Selenium modulation of cell proliferation and cell cycle biomarkers in normal and premalignant cells of the rat mammary gland. Cancer Epidemiol Biomarkers Prev. 9:2000;49-54.
122. Reddy B.S., Rivenson A., El Bayoumi K., Upadhyaya P., Pittman B., Rao C.V. Chemoprevention of colon cancer by organoselenium compounds and impact of high- or low-fat diet. J Natl Cancer Inst. 89:1997;506-512.
123. El-Bayoumi K., Chae Y.-H., Upadhyaya P., et al. Selenium in chemoprevention of carcinogenesis II. Inhibition of 7,12-dimethyl-benz(a)anthracene induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound 1,4-phenylenebis (methylene)selenocyanate. Cancer Res. 52:1992;2402-2407.
124. Ip C., El-Bayoumi K., Upadhyaya P., et al. Comparative effect of inorganic and organic selenocyanate derivatives in mammary cancer chemoprevention. Carcinogenesis. 15:1994;187-192.
125. Thompson H.J., Wilson A., Lu J., et al. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis. 15:1994;183-186.
126. Tillotson J.K., Upadhyaya P., Ronai Z. Inhibition of thymidine kinase in cultured mammary tumor cells by the chemopreventive organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Carcinogenesis. 15:1994;597-601.
127. Favier A., Sappey C., Leclerc P., Faure P., Micoud M. Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact. 91:1994;165-180.
128. Dobmeyer T.S., Findhammer S., Dobmeyer J.M., Klein S.A., Raffel B., Hoelzer D., et al. Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol M. 22:1997;775-785.
129. Pace G.W., Leaf C.D. The role of oxidative stress in HIV disease. Free Radic Biol M. 19:1995;523-528.
130. Mallery S.R., Bailer R.T., Hohl C.M., Ng-Bautista C.L., Ness G.M., Livingston B.E., et al. Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis. J Cell Biochem. 59:1995;317-328.
131. Dewhurst S., Gelbard H.A., Fine S.M. Neuropathogenesis of AIDS. Mol Med Today. 2:1996;16-23.
132. Muller F., Svardal A.M., Aukrust P., Berge R.K., Ueland P.M., Froland S.S. Elevated plasma concentration of reduced homocysteine in patients with human immunodeficiency virus infection. Am J Clin Nutr. 63:1996;242-248.
133. Aukrust P., Svardal A.M., Muller F., Lunden B., Berge R.K., Ueland P.M., et al. Increased levels of oxidized glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood. 86:1995;258-267.
134. Baum M.K., Shor-Posner G. Micronutrient status in relationship to mortality in HIV-1 disease. Nutr Rev. 56:1998;S135-S139.
135. Tang A.M., Graham N.M., Semba R.D., Saah A.J. Association between serum vitamin A and E levels and HIV-1 disease progression. AIDS. 11:1997;613-620.
136. Look M.P., Rockstroh J.K., Rao G.S., Kreuzer K.A., Spengler U., Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res. 56:1997;31-41.
137. Moutet M., d'Alessio P., Malette P., Devaux V., Chaudiere J. Glutathione peroxidase mimics prevent TNF-alpha- and neutrophil-induced endothelial alterations. Free Radic Biol M. 25:1998;270-281.
138. Roy M., Kiremidjian-Schumacher L., Wishe H.I., Cohen M.W., Stotzky G. Selenium supplementation enhances the expression of interleukin 2 receptor subunits and internalization of interleukin 2. Proc Soc Exp Biol M. 202:1993;295-301.
139. Haslett P.A. Anticytokine approaches to the treatment of anorexia and cachexia. Semin Oncol. 25:1998;53-57.
140. Hori K., Hatfield D., Maldarelli F., Lee B.J., Clouse K.A. Selenium supplementation suppresses tumor necrosis factor alpha-induced human immunodeficiency virus type 1 replication in vitro. AIDS Res Hum Retroviruses. 13:1997;1325-1332.
141. Delmas-Beauvieux M.C., Peuchant E., Couchouron A., Constans J., Sergeant C., Simonoff M., et al. The enzymatic antioxidant system in blood and glutathione status in human immunodeficiency virus (HIV)-infected patients: effects of supplementation with selenium or beta-carotene. Am J Clin Nutr. 64:1996;101-107.
142. Cirelli A., Ciardi M., de Simone C., Sorice F., Giordano R., Ciaralli L., et al. Serum selenium concentration and disease progress in patients with HIV infection. Clin Biochem. 24:1991;211-214.
143. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408:2000;239-247.
144. Lesourd B.M. Nutrition and immunity in the elderly: modification of immune responses with nutritional treatments. Am J Clin Nutr. 66:1997;478S-484S.
145. Mazari L., Lesourd B.M. Nutritional influences on immune response in healthy aged persons. Mech Ageing Dev. 104:1998;25-40.
146. Albright J.W., Albright J.F. Impaired natural killer cell function as a consequence of aging. Exp Gerontol. 33:1998;13-25.
147. Olivieri O., Girelli D., Azzini M., Stanzial A.M., Russo C., Ferroni M., et al. Low selenium status in the elderly influences thyroid hormones. Clin Sci (Lond). 89:1995;637-642.
148. Olivieri O., Girelli D., Stanzial A.M., Rossi L., Bassi A., Corrocher R. Selenium, zinc, and thyroid hormones in healthy subjects: low T3/T4 ratio in the elderly is related to impaired selenium status. Biol Trace Elem Res. 51:1996;31-41.
149. Ruz M., Codoceo J., Galgani J., Munoz L., Gras N., Muzzo S., et al. Single and multiple selenium-zinc-iodine deficiencies affect rat thyroid metabolism and ultrastructure. J Nutr. 129:1999;174-180.
150. Savarino L., Granchi D., Ciapetti G., Cenni E., Ravaglia G., Forti P., et al. Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians. Exp Gerontol. 36:2001;327-339.
151. Kauf E., Dawczynski H., Jahreis G., Janitzky E., Winnefeld K. Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital hypothyroidism. Biol Trace Elem Res. 40:1994;247-253.
152. Serra V., Grune T., Sitte N., Saretzki G., von Zglinicki T. Telomere length as a marker of oxidative stress in primary human fibroblast cultures. Ann NY Acad Sci. 908:2000;327-330.